Safa Baris

Genalyse (Genalyse Genetic & Reporting Ltd.) is a clinical bioinformatics company based in Istanbul, Turkey, specializing in AI-driven genomic and transcriptomic analysis. The company provides comprehensive services including Whole Exome Sequencing (WES), Whole Genome Sequencing (WGS), and RNA-Seq interpretation to healthcare providers and researchers. Prof. Dr. Safa Baris serves as the Chief Medical Officer, bringing extensive expertise in pediatric allergy and immunology to the company's clinical reporting. Genalyse focuses on identifying genetic variants associated with rare diseases, inborn errors of immunity, and cancer to support personalized medicine and clinical research.